Denise Barrow

发表

Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Ian O Ellis, I. Ellis, J. Robertson, 2007, Breast Cancer Research.

Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells.

R. Nicholson, J. Gee, I. Hutcheson, 2003, Endocrinology.

Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib (‘Iressa’) response and resistance

R. Nicholson, I. Hutcheson, J. Knowlden, 2008, Breast Cancer Research and Treatment.

New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies.

Andrea Brancale, Gabriela Chiosis, Ernest Hamel, 2006, Journal of medicinal chemistry.